Regulation of Inflammatory Response by Transmembrane Adaptor Protein LST1.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 16 10 2020
accepted: 08 04 2021
entrez: 14 5 2021
pubmed: 15 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

LST1 is a small adaptor protein expressed in leukocytes of myeloid lineage. Due to the binding to protein tyrosine phosphatases SHP1 and SHP2 it was thought to have negative regulatory function in leukocyte signaling. It was also shown to be involved in cytoskeleton regulation and generation of tunneling nanotubes.

Identifiants

pubmed: 33986741
doi: 10.3389/fimmu.2021.618332
pmc: PMC8111073
doi:

Substances chimiques

Biomarkers 0
Intracellular Signaling Peptides and Proteins 0
LST1 protein, human 0
Lipopolysaccharides 0
Membrane Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

618332

Informations de copyright

Copyright © 2021 Fabisik, Tureckova, Pavliuchenko, Kralova, Balounova, Vicikova, Skopcova, Spoutil, Pokorna, Angelisova, Malissen, Prochazka, Sedlacek and Brdicka.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Bone Miner Res. 2019 Apr;34(4):681-698
pubmed: 30690795
World J Gastroenterol. 2012 Nov 7;18(41):5848-61
pubmed: 23139600
J Vis Exp. 2018 Oct 30;(140):
pubmed: 30451235
Immunobiology. 2018 Nov;223(11):699-708
pubmed: 30055863
Mucosal Immunol. 2013 Sep;6(5):1016-26
pubmed: 23340823
Nat Immunol. 2008 Oct;9(10):1091-4
pubmed: 18800157
Gastroenterology. 1994 Dec;107(6):1643-52
pubmed: 7958674
PLoS One. 2012;7(7):e41169
pubmed: 22815957
Genomics. 1996 Jan 15;31(2):215-22
pubmed: 8824804
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Cell Mol Gastroenterol Hepatol. 2015 Mar 1;1(2):154-170
pubmed: 26000334
Am J Pathol. 2011 Feb;178(2):735-43
pubmed: 21281806
Hybridoma (Larchmt). 2009 Aug;28(4):281-6
pubmed: 19663701
Genomics. 1997 Nov 1;45(3):591-600
pubmed: 9367684
Front Endocrinol (Lausanne). 2021 Feb 19;11:620466
pubmed: 33679604
Clin Exp Rheumatol. 2016 Jul-Aug;34(4):685-9
pubmed: 27384923
Inflamm Res. 2014 Jul;63(7):513-7
pubmed: 24682411
Oncotarget. 2017 Oct 30;8(58):98945-98952
pubmed: 29228739
BMC Genomics. 2012 Aug 20;13:411
pubmed: 22905720
Mucosal Immunol. 2016 Jul;9(4):974-85
pubmed: 26555704
Gut. 2006 Mar;55(3):334-41
pubmed: 16162679
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3716-24
pubmed: 27303036
J Immunol. 2009 Aug 1;183(3):2037-44
pubmed: 19596985
Nature. 2016 Sep 22;537(7621):508-514
pubmed: 27626380
J Biol Chem. 2012 Jun 29;287(27):22812-21
pubmed: 22589543
Hum Immunol. 2013 Apr;74(4):412-6
pubmed: 23228397
Exp Cell Res. 2018 Jan 15;362(2):349-361
pubmed: 29208460
Immune Netw. 2018 Aug 21;18(4):e30
pubmed: 30181918
J Bone Miner Res. 2012 Jun;27(6):1357-67
pubmed: 22407806
Virol J. 2016 Jan 27;13:17
pubmed: 26817701
J Cell Sci. 2013 Feb 1;126(Pt 3):767-77
pubmed: 23239025
BMC Immunol. 2019 Nov 12;20(1):42
pubmed: 31718550
J Immunol. 2000 Mar 15;164(6):3169-76
pubmed: 10706707
Am J Physiol. 1998 Mar;274(3):G544-51
pubmed: 9530156
World J Gastroenterol. 2017 Sep 7;23(33):6016-6029
pubmed: 28970718
Stem Cell Res Ther. 2018 May 22;9(1):146
pubmed: 29784012
Curr Osteoporos Rep. 2020 Dec;18(6):677-683
pubmed: 33030683

Auteurs

Matej Fabisik (M)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
Faculty of Science, Charles University, Prague, Czechia.

Jolana Tureckova (J)

Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Nataliia Pavliuchenko (N)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
Faculty of Science, Charles University, Prague, Czechia.

Jarmila Kralova (J)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.

Jana Balounova (J)

Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Kristina Vicikova (K)

Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Tereza Skopcova (T)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.

Frantisek Spoutil (F)

Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Jana Pokorna (J)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.

Pavla Angelisova (P)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.

Bernard Malissen (B)

Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, Marseille, France.

Jan Prochazka (J)

Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Radislav Sedlacek (R)

Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czechia.

Tomas Brdicka (T)

Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH